On August 2, 2022, the Company issued 9,200,000 shares of the Company’s common stock, par value $0.01 per share, pursuant to a Purchase Agreement, dated July 28, 2022 , among the Company, Ares Capital Management LLC, Ares Operations LLC and Morgan Stanley & Co. LLC, BofA Securities, Inc. and UBS Securities LLC, as representatives of the several underwriters named on Schedule A thereto (collectively, the “Underwriters”). This included 1,200,000 shares of Common Stock that the Underwriters purchased pursuant to an option granted to them by the Company under the terms of the Purchase Agreement.

The Shares were purchased by the Underwriters from the Company at a price of $19.00 per share, resulting in net proceeds to the Company of approximately $174.4 million, after deducting discounts and commissions and estimated offering expenses.

The Shares were offered and sold pursuant to the Registration Statement on Form N-2 (File No. 333-256733) and a preliminary prospectus supplement, dated July 28, 2022, and accompanying prospectus, dated June 3, 2021, filed with the Securities and Exchange Commission. As of 2022-08-04, fund’s market price was $19.73 and NAV was $18.81.